(Q43352672)

20 November 2017

title

Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers (English)

1 reference

20 November 2017

main subject

irritable bowel syndrome

1 reference

1 reference

Clemens CH

1 reference

20 November 2017

Samsom M

1 reference

20 November 2017

Van Berge Henegouwen GP

1 reference

20 November 2017

Fabri M

1 reference

20 November 2017

Smout AJ

1 reference

20 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Alimentary Pharmacology & Therapeutics

20 November 2017

published in

1 reference

20 November 2017

1 reference

20 November 2017

1 reference

20 November 2017

page(s)

993-1002

1 reference

Review article: irritable bowel syndrome

20 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

The motility of the pelvic colon: Part II Paradoxical motility in diarrhoea and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Colonic tone and motility in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Colonic mass movements in idiopathic chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Evidence for two distinct perceptual alterations in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Distension-stimulated propagated contractions in human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Review article: the role of inflammation in the pathogenesis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

A novel portable perfused manometric system for recording of small intestinal motility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Variability of gastrointestinal transit in healthy women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Serotonergic mediation of postprandial colonic tonic and phasic responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

5-Hydroxytryptamine and functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2002.01252.X

10.1046/J.1365-2036.2002.01252.X

21 January 2018

Identifiers

DOI

1 reference

20 November 2017

1 reference